Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases
Tuesday April 25, 2017 3:30 pm to 5:30 pm
Epilepsy/Clinical Neurophysiology (EEG)
Joseph Sirven MD, FAAN
Faculty will use a "headline news" approach to highlight important epilepsy clinical information, and a rapid fire, multi-topic case-based approach with video to provide salient pithy updates on numerous epilepsy topics. Topics will include new treatments, and when to use them; how to manage seizure emergencies; the evidence base for the risks and benefits of cannabis in epilepsy patients; how to approach decisions on devices and diagnosing; and treating immune causes of epilepsy.
Participants should be able list or identify all currently available medication and device treatments for epilepsy; understand the management of acute seizure emergencies; know when to consider immune-based diagnoses and treatments for epilepsy, as well as surgical interventions; know how to counsel on driving laws for epilepsy; and understand where current thought stands on cannabis for epilepsy.
Medical Knowledge, Patient Care
Program Speakers - Tentative
3:30 PM - 3:35 PM
Joseph I. Sirven MD, FAAN
3:35 PM - 5:25 PM
Matthew T. Hoerth MD, Joseph I. Sirven MD, FAAN, Angus Wilfong MD
5:25 PM - 5:30 PM
Questions and Answers
Matthew T. Hoerth, MD
Dr. Hoerth has nothing to disclose.
Joseph I. Sirven, MD, FAAN
Dr. Sirven has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB.
Angus Wilfong, MD
Dr. Wilfong has received research support from Novartis, Pfizer, UCB, Inc, Upsher-Smith, Lundbeck, GW Pharma, and Eisai.
Ready to register for the 2018 AAN Annual Meeting?